Cadisegliatin 800 mg QD
TTP399-302
Phase 3 small_molecule active
Quick answer
Cadisegliatin 800 mg QD for Diabetes Mellitus, Type 1 is a Phase 3 program (small_molecule) at vTv Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- vTv Therapeutics
- Indication
- Diabetes Mellitus, Type 1
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active